Study finds some people less susceptible to H7N9 influenza virus than others

January 7, 2014 by Bob Yirka report
Influenza A (H7N9) as viewed through an electron microscope. Both filaments and spheres are observed in this photo. Credit: CDC

(Medical Xpress)—An international team of researchers working at the University of Melbourne in Australia has found that genetic differences in people result in different degrees of ability to fight the H7N9 influenza virus. In their paper published in Proceedings of the National Academy of Sciences, the team reports that their study of immune response observed in blood samples indicates that some people may be far better equipped to fight off the new flu strain than others.

After observing differing degrees of in obtained from 52 human donors, the researchers looked a little closer to discover why it occurred and whether something could be done about it. In so doing, they discovered that a difference in a protein complex that is part of the immune response was responsible for the different immune response levels.

The H7N9 first appeared in China, in February of last year (likely after jumping from domestic fowl—137 were infected, 45 died) and as such, has never before been seen in humans. Because of that, people have no antibodies ready to go to war upon recognition of the virus. Some people, however, have a type of lymphocyte (CD8+ T) that serves in its stead—they generally come to exist after battling some other type of flu strain. Often, the result is some degree of immune response, which aids in fighting off the virus. Those that don't have the lymphocyte are left to fight the virus as an unknown foreign entity, which means a broad response –one that is far less effective in overcoming the virus.

The team notes that there appears to be a regional factor involved—those people native to Alaska and Australia, for example, tend to not have the lymphocyte and are thus much more susceptible to the symptoms of the .

More specifically, the researchers found that 16 to 57 percent of people in the study (which they believe corresponds roughly to the general population) had some degree of immune response due to CD8+ T—some of which appeared to respond to any that was introduced. That of course leaves a large portion of the public at risk.

To counter the , researchers are working on a universal T-cell vaccine that would supplement the normal flu vaccine that people already have access to—the hope is that it can be developed before late winter in the northern hemisphere—the time when the virus would become most prevalent.

Explore further: Universal flu vaccine may be a step closer

More information: Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities, PNAS, www.pnas.org/content/early/2014/01/03/1322229111

Abstract
The absence of preexisting neutralizing antibodies specific for the novel A (H7N9) influenza virus indicates a lack of prior human exposure. As influenza A virus–specific CD8+ T lymphocytes (CTLs) can be broadly cross-reactive, we tested whether immunogenic peptides derived from H7N9 might be recognized by memory CTLs established following infection with other influenza strains. Probing across multiple ethnicities, we identified 32 conserved epitopes derived from the nucleoprotein (NP) and matrix-1 (M1) proteins. These NP and M1 peptides are presented by HLAs prevalent in 16–57% of individuals. Remarkably, some HLA alleles (A*0201, A*0301, B*5701, B*1801, and B*0801) elicit robust CTL responses against any human influenza A virus, including H7N9, whereas ethnicities where HLA-A*0101, A*6801, B*1501, and A*2402 are prominent, show limited CTL response profiles. By this criterion, some groups, especially the Alaskan and Australian Indigenous peoples, would be particularly vulnerable to H7N9 infection. This dissection of CTL-mediated immunity to H7N9 thus suggests strategies for both vaccine delivery and development.

Related Stories

Universal flu vaccine may be a step closer

August 16, 2013
(Medical Xpress)—A new study in the US suggests that boosting a certain group of antibodies could help to create a universal vaccine for influenza.

Scientists closer to universal flu vaccine after pandemic 'natural experiment'

September 22, 2013
Scientists have moved closer to developing a universal flu vaccine after using the 2009 pandemic as a natural experiment to study why some people seem to resist severe illness.

Bird flu expert working on vaccine that protects against multiple strains

May 10, 2013
(Medical Xpress)—As the bird flu outbreak in China worsens, a Purdue University expert is working on vaccines that offer broader protection against multiple strains of the virus.

China says woman died from bird flu new to humans

December 18, 2013
Chinese authorities said Wednesday that a 73-year-old Chinese woman died after being infected with a bird flu strain that had sickened a human for the first time, a development that the World Health Organization called "worrisome."

Older mice fed wolfberries show reduced risk for flu virus with vaccine

December 11, 2013
In a study of older mice, wolfberries appear to interact with the influenza vaccine to offer additional protection against the flu virus. The research, led by scientists at the Jean Mayer USDA Human Nutrition Research Center ...

PDL-1 antibody could help immune system fight off influenza viral infection, study suggests

December 23, 2013
An antibody that blocks a component of a key signaling pathway in the respiratory airways could help the immune system rid the body of the influenza virus, a new study suggests. The findings, from a team at The Research Institute ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.